The Urbanist | October 30, 2025
According to Sarah Cusworth Walker, PhD, MS and Katherine Beckett, the PAO's decision to pause referrals to Restorative Community Pathways is unsupported by the available data.
Research & Innovation
Population Health Initiative awards early-stage pilot grants
Department News | November 26, 2025
The UW Population Health Initiative has awarded eight, $25,000 Tier 1 pilot grants to interdisciplinary teams of UW researchers. These teams collectively represent 10 UW schools and colleges plus several community-based partners, including three projects with investigators from our department.
New faculty to focus on digital innovation and artificial intelligence
Department News | November 26, 2025
We’re happy to announce that Devon Sandel-Fernandez, PhD and Adam Kuczynski, PhD have been selected to lead our department’s efforts in digital innovation and artificial intelligence.
ADHD diagnoses are growing. What’s going on?
Nature | November 26, 2025
Info online connects with some people who have had symptoms but never understood what they were, says Margaret Sibley, PhD. That leads them to seek help, pushing diagnoses up.
Disabling cannabis gets formal clinical identity
UW Medicine Newsroom | November 18, 2025
"A new code for cannabis hyperemesis syndrome will supply important hard evidence on cannabis-adverse events, which physicians tell us is a growing problem,” says Beatriz Carlini, PhD, MPH.
Syndrome linked to chronic cannabis use gets formal ID by World Health Organization
KOMO News | November 19, 2025
Now that we have a name, we can better educate society that, yes, cannabis helps control nausea in some people, but for others it's the exact opposite, explains Beatriz Carlini, PhD, MPH.
Post-traumatic stress disorder treatable in primary care
UW Medicine Newsroom | October 21, 2025
“These findings suggest primary-care providers can deliver proven PTSD treatments that improve patient outcomes,” says John Fortney, PhD.
Text therapy to ease depression; study finds evidence
DT Next | November 10, 2025
"We were pleasantly surprised to see that it was as good as weekly video therapy,” said Patricia Areán, PhD. "We didn't really find any differences in the outcomes."
Primary care’s role in PTSD treatment
Conexiant Psychiatry | November 10, 2025
Led by John Fortney, PhD, study found that written exposure therapy and SSRIs both reduced PTSD symptoms in primary care, while switching to venlafaxine benefited non responders.
Clarivate announces 2025 list of highly cited researchers
UW Medicine Newsroom | November 12, 2025
The list recognizes scientists such as Cara Lewis, PhD and Aaron Lyon, PhD whose papers significantly influence the work of other researchers.
